Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas
- 13 April 2006
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 78 (3) , 233-247
Abstract
Summary Introduction Hypoxia inducible factor-1α (HIF-1α) regulates vascular endothelial growth factor (VEGF), the presumed principal mediator of angiogenesis in malignant gliomas, under normal physiologic conditions. We examined the effect of HIF-1α on VEGF secretion, tumor growth, and angiogenesis in malignant gliomas. Methods We examined 175 human gliomas for expression of HIF-1α and its downstream-regulated proteins. HIF-1α expression and VEGF secretion in glioma cell lines under normoxia and hypoxia were examined using␣ELISA and Western blot. Malignant glioma cell lines were transfected with dominant-negative HIF-1α (DN-HIF-1α) expression vector or siRNA constructs against the HIF-1α gene. Growth studies were conducted on cells with the highest VEGF/HIF-1α inhibition isolated from stable transfected cell lines. MIB-1-labeling index and microvascular density (MVD) measurements were performed on the in vivo tumors. Results HIF-1 expression correlates with malignant glioma phenotype and was not confined to perinecrotic, pseudopalisading cells. VEGF and HIF-1 expression was high in glioma cell lines even under normoxia, and increased after exposure to hypoxia or growth factor stimulation. Cells transfected with DN-HIF-1α or HIF-1α siRNA demonstrated decreased HIF-1α and VEGF secretion. In vivo but not in vitro growth decreased in response to VEGF and HIF-1 inhibition. HIF-1 siRNA studies showed decreased VEGF secretion and in vitro and in vivo growth of glioma cell lines. MVD was unchanged but MIB-1 proliferation index decreased for both types of HIF-1 inhibition. Conclusions VEGF and HIF-1α are elevated in malignant gliomas. HIF-1α inhibition results in VEGF secretion inhibition. HIF-1α expression affects glioma tumor growth, suggesting clinical applications for malignant glioma treatment.Keywords
This publication has 66 references indexed in Scilit:
- Differential regulation of VEGF, HIF1α and angiopoietin‐1, ‐2 and ‐4 by hypoxia and ionizing radiation in human glioblastomaInternational Journal of Cancer, 2003
- Expression of hypoxia‐inducible factor 1α in tumours of patients with glioblastomaNeuropathology and Applied Neurobiology, 2002
- Binding and regulation of HIF‐1α by a subunit of the proteasome complex, PSMA7FEBS Letters, 2001
- Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomasNeuro-Oncology, 2000
- Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomasNeuro-Oncology, 2000
- Regulation by Neurotransmitter Receptors of Serotonergic or Catecholaminergic Neuronal Cell DifferentiationJournal of Biological Chemistry, 2000
- Angiogenesis: How a Tumor Adapts to HypoxiaBiochemical and Biophysical Research Communications, 1999
- Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1Annual Review of Cell and Developmental Biology, 1999
- Inhibition of In Vitro Meningioma Proliferation after Growth Factor Stimulation by Calcium Channel AntagonistsNeurosurgery, 1995
- Inhibition of In Vitro Meningioma Proliferation after Growth Factor Stimulation by Calcium Channel AntagonistsNeurosurgery, 1995